Host DNA contents in fecal metagenomics as a biomarker for intestinal diseases and effective treatment

BACKGROUND: Compromised intestinal barrier (CIB) has been associated with many enteropathies, including colorectal cancer (CRC) and inflammatory bowel disease (IBD). We hypothesized that CIB could lead to increased host-derived contents including epithelial cells into the gut, change its physio-meta...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Puzi, Lai, Senying, Wu, Sicheng, Zhao, Xing-Ming, Chen, Wei-Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7216530/
https://www.ncbi.nlm.nih.gov/pubmed/32393180
http://dx.doi.org/10.1186/s12864-020-6749-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7216530/
https://www.ncbi.nlm.nih.gov/pubmed/32393180
http://dx.doi.org/10.1186/s12864-020-6749-z

Ejemplares similares